ISSN: 2296-5270

Journal Home

Journal Guideline

Oncology Research and Treatment Q3 Unclaimed

S. Karger AG Switzerland

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncology Research and Treatment is a journal indexed in SJR in Hematology and Oncology with an H index of 55. It has an SJR impact factor of 0,521 and it has a best quartile of Q3. It has an SJR impact factor of 0,521.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q3) Hematology (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,521

SJR Impact factor

55

H Index

67

Total Docs (Last Year)

283

Total Docs (3 years)

2025

Total Refs

448

Total Cites (3 years)

264

Citable Docs (3 years)

1.41

Cites/Doc (2 years)

30.22

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Advances in Hematology Q3
Clinical Lymphoma, Myeloma and Leukemia Q3
Lymphology Q3
Hematology Q3
Journal of Blood Medicine Q3

Compare this journals

Aims and Scope

Best articles by citations

Malpractice in Oncology

Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis

Drug Resistance in Human Melanoma: Mechanisms and Therapeutic Opportunities

Taxane in der primären systemischen Therapie des Mammakarzinoms

Capecitabine as Salvage Therapy for a Breast Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function

Tumor-Related Fatigue -an Underestimated Problem

Time for Progress

Docetaxel fur die neoadjuvanten Therapieansätze der fruhen Stadien des nicht-kleinzelligen Bronchuskarzinoms

Palliative Therapie des kolorektalen Karzinoms

Recent Results in Understanding Molecular Pathways in the Medical Treatment of Esophageal and Gastric Cancer

Palliative Therapie des Mammakarzinoms

New Concepts of Staging in Gastrointestinal Tumors as a Basis of Diagnosis and Multimodal Therapy

SHOW MORE ARTICLES

The Radioprotectors Amifostine and Sodium Selenite Do Not Modify the Radiosensitivity of Rat Rhabdomyosarcomas

Impact of Inguinal Dissection on Prognosis of Early-Stage Squamous Cell Carcinoma of the Vulva -a Retrospective Analysis

Definitive and Neoadjuvant Radiochemotherapy of Squamous Cell Carcinoma of the Oesophagus

Bedeutung von Docetaxel fur die Chemotherapie des hormonrefraktären Prostatakarzinoms

Neue Chemotherapeutika in der Therapie des fortgeschrittenen Magenkarzinoms

Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours

Surgical Treatment of Locally Advanced and Recurrent Cervical Carcinoma: Overview on Current Standard and New Developments

Typical Medication Errors in Oncology: Analysis and Prevention Strategies

A Note from the Editor

Pirarubicin in Advanced Non-Small Cell Lung Cancer

Consent and Equipoise, the Crucial Ethical Issues in Randomised Clinical Trials

Clinical Research and Industrial Sponsoring: Avenues towards Transparency and Credibility